Exai Bio Inc

Aulisa Medical Technologies Inc is a Palo Alto-based medical device company founded in 2012 by Augie Lien. They specialize in developing FDA cleared, wireless, wearable patient monitoring systems that provide continuous, cloud-based vital sign information for both clinical and at-home environments. Their mission is to leverage artificial intelligence and digital health to develop continuous monitoring products that alert users to inconsistencies in vital sign data, enabling early detection and intervention for potentially adverse events. Aulisa Medical's products are available for infants, children, and adults, and their Guardian Angel monitoring systems serve as baby monitors for infants, provide key vitals monitoring for children during illness or treatments, and offer remote monitoring for adults with chronic respiratory or heart diseases. Their innovative technology aims to reduce the manual burden of spot checking vital signs for both clinicians and caregivers.Generated from the website

Middle Peak Medical is a privately held medical device company based in Palo Alto, California. They are focused on developing a breakthrough device to address unmet needs in the treatment of mitral valve disease, which is the most common form of heart valve disease in the U.S. and Europe. Their technology has applications in both minimally invasive cardiac surgery and catheter-based percutaneous intervention. The company has filed 17 patents related to cardiac anatomy, cardiac surgery, and cardiology. With a total raised funding of $11.5 million, Middle Peak Medical has attracted investments from notable investors such as Symetis, Seventure Partners, Wellington Partners, Edwards Lifesciences, and BioMedPartners.Generated from the website

DiscernDx, based in Palo Alto, CA, is a pioneering healthcare company that aims to revolutionize the way individuals manage their health. By providing access to personalized clinical and molecular data, DiscernDx empowers individuals to proactively monitor their health, detect diseases early, and make informed decisions about their care. With a holistic and molecular-level approach, DiscernDx's innovative system detects, measures, and interprets signals from the body's systems simultaneously, enabling the identification of developing diseases and existing conditions. By combining phenotypic and multi-omics data, utilizing artificial intelligence, and leveraging years of rigorous science and technology development, DiscernDx is committed to removing barriers to vital health information and transforming healthcare for the better.Generated from the website